{"transactions":[{"id":3256082,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":151475,"kind":"person","name":"Blake John T","position":1,"cik":"0001657162","reported_name":"Blake John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units(RSUs)","published_at":"2020-02-21T22:27:06.000Z","date":"2020-02-19","kind":"exercise","acquired":false,"shares":2563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest over four years, in equal annual installments, subject to continuous employment."}],"balance_after":7687,"derivative":{"exercise_price":0,"exercise_date":"2020-02-19","expiration_date":"2023-02-19","underlying":"Common Stock","underlying_shares":10250},"source":{"system":"sec-edgar","filing":"0001209191-20-011655","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000120919120011655/doc4.xml","form_type":"4"}},{"id":3256081,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":151475,"kind":"person","name":"Blake John T","position":1,"cik":"0001657162","reported_name":"Blake John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-21T22:27:06.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":809,"price":5.44,"value":4400.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"809 shares were sold to satisfy the tax withholding obligations on vesting and release of common stock from RSUs"}],"balance_after":1754,"source":{"system":"sec-edgar","filing":"0001209191-20-011655","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000120919120011655/doc4.xml","form_type":"4"}},{"id":3256080,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":151475,"kind":"person","name":"Blake John T","position":1,"cik":"0001657162","reported_name":"Blake John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-21T22:27:06.000Z","date":"2020-02-19","kind":"grant","acquired":true,"shares":2563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"2,563 shares of common stock acquired upon partial vesting and release of common stock from restricted stock units(RSUs)."}],"balance_after":2563,"source":{"system":"sec-edgar","filing":"0001209191-20-011655","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000120919120011655/doc4.xml","form_type":"4"}},{"id":3270261,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":151475,"kind":"person","name":"Blake John T","position":1,"cik":"0001657162","reported_name":"Blake John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified Stock Option(right to buy)","published_at":"2020-02-14T19:16:23.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":20147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vest over four years from the grant date in equal monthly installments, subject to continuous employment, such that the total number shall be fully vested on the four-year anniversary of the transaction date."}],"balance_after":20147,"derivative":{"exercise_price":5.98,"exercise_date":"2020-03-12","expiration_date":"2030-02-12","underlying":"Common Stock","underlying_shares":20147},"source":{"system":"sec-edgar","filing":"0001209191-20-009541","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000120919120009541/doc4.xml","form_type":"4"}},{"id":3641479,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":151475,"kind":"person","name":"Blake John T","position":1,"cik":"0001657162","reported_name":"Blake John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units(RSUs)","published_at":"2019-02-22T00:24:07.000Z","date":"2019-02-19","kind":"grant","acquired":true,"shares":82000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest over four years, in equal annual installments, subject to continuous employment."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest over four years, in equal annual installments, subject to continuous employment."}],"balance_after":82000,"derivative":{"exercise_price":0,"exercise_date":"2020-02-19","underlying":"Common Stock","underlying_shares":82000},"source":{"system":"sec-edgar","filing":"0001209191-19-012297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000120919119012297/doc4.xml","form_type":"4"}},{"id":3641478,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":151475,"kind":"person","name":"Blake John T","position":1,"cik":"0001657162","reported_name":"Blake John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified Stock Option(right to buy)","published_at":"2019-02-22T00:24:07.000Z","date":"2019-02-19","kind":"grant","acquired":true,"shares":163000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vest over four years from the grant date in equal monthly installments, subject to continuous employment, such that the total number shall be fully vested on the four-year anniversary of the transaction date."}],"balance_after":163000,"derivative":{"exercise_price":0.7401,"exercise_date":"2019-03-19","expiration_date":"2029-02-19","underlying":"Common Stock","underlying_shares":163000},"source":{"system":"sec-edgar","filing":"0001209191-19-012297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000120919119012297/doc4.xml","form_type":"4"}},{"id":4070143,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":151475,"kind":"person","name":"Blake John T","position":1,"cik":"0001657162","reported_name":"Blake John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Restricted Stock Units","published_at":"2018-02-09T01:43:18.000Z","date":"2018-02-07","kind":"exercise","acquired":false,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 7, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSU grant vests as to one-third (1/3) of the total number of units on each one year anniversary of the grant commencing on February 7, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSU grant vests as to one-third (1/3) of the total number of units on each one year anniversary of the grant commencing on February 7, 2018."}],"balance_after":6666,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001209191-18-008618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919118008618/doc4.xml","form_type":"4"}},{"id":4070142,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":151475,"kind":"person","name":"Blake John T","position":1,"cik":"0001657162","reported_name":"Blake John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-02-09T01:43:18.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 6, 2018, such that this option will be fully exercisable on February 6, 2022.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":75000,"derivative":{"exercise_price":3.3,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-18-008618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919118008618/doc4.xml","form_type":"4"}},{"id":4070141,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":151475,"kind":"person","name":"Blake John T","position":1,"cik":"0001657162","reported_name":"Blake John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2018-02-09T01:43:18.000Z","date":"2018-02-08","kind":"sale","acquired":false,"shares":1402,"price":3.4,"value":4766.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sale made by the Reporting Person in compliance with the provisions of Rule 10b5-1 to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 7, 2017."}],"balance_after":1932,"source":{"system":"sec-edgar","filing":"0001209191-18-008618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919118008618/doc4.xml","form_type":"4"}},{"id":4070140,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":151475,"kind":"person","name":"Blake John T","position":1,"cik":"0001657162","reported_name":"Blake John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2018-02-09T01:43:18.000Z","date":"2018-02-07","kind":"exercise","acquired":true,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 7, 2017."}],"balance_after":3334,"source":{"system":"sec-edgar","filing":"0001209191-18-008618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919118008618/doc4.xml","form_type":"4"}},{"id":4459257,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":151475,"kind":"person","name":"Blake John T","position":1,"cik":"0001657162","reported_name":"Blake John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Restricted Stock Unit","published_at":"2017-02-09T21:06:32.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units (RSUs) are scheduled to vest in three equal annual installments beginning on February 7, 2018, such that this grant will be fully vest on February 7, 2020. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units (RSUs) are scheduled to vest in three equal annual installments beginning on February 7, 2018, such that this grant will be fully vest on February 7, 2020. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-009051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919117009051/doc4.xml","form_type":"4"}},{"id":4459256,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":151475,"kind":"person","name":"Blake John T","position":1,"cik":"0001657162","reported_name":"Blake John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option  (right to buy)","published_at":"2017-02-09T21:06:32.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 7, 2017, such that this option will be fully exercisable on February 7, 2021.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":55000,"derivative":{"exercise_price":3.3,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-17-009051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919117009051/doc4.xml","form_type":"4"}},{"id":4602446,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":151475,"kind":"person","name":"Blake John T","position":1,"cik":"0001657162","reported_name":"Blake John T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-09-15T22:37:36.000Z","date":"2016-09-13","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning October 13, 2016, such that this option will be fully exercisable on September 13, 2020.  This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer."}],"balance_after":19000,"derivative":{"exercise_price":3.06,"expiration_date":"2026-09-13","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001209191-16-141649","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919116141649/doc4.xml","form_type":"4"}}]}